LicianPro

HCMAW stock · MSFT stock · Lician Pro · $19.99/mo or $149/yr · These side-by-side numbers as JSON? API free 100/day

HCMAW vs MSFT

HCM Acquisition Corp Warrant (HCMAW) versus Microsoft Corporation (MSFT) — a side-by-side from cached financials, not a winner call.

HCM Acquisition Corp Warrant (HCMAW) is a shell companies company listed on NASDAQ.

Microsoft Corporation (MSFT) is a software - infrastructure company listed on US. It is led by Satya Nadella.

HCMAW does not have a complete income-statement cache yet.

Latest reported MSFT revenue for 2026-06-30 was $331.84B. Net income was $133.75B. Revenue was up 17.8% from 2025-06-30 to 2026-06-30. MSFT currently screens at market cap $3.71T.

MSFT currently screens at market cap $3.71T.

Not investment advice. Open the HCMAW and MSFT stock pages for the full models.

Basic comparison

Price, market cap, and trailing P/E stay on this page.

HCMAW vs MSFT
MetricHCMAWMSFT
Price$0.34$520.99
Market cap—$3.71T
Trailing P/E——

Deeper peer metrics

Net income and multi-year revenue growth are the peek. More peer metrics open below. This block stops at the labels.

More peer metrics

Operating margin, EPS, free cash flow, and gross margin are on Pro.

Unlock deeper peer metrics

These side-by-side numbers as JSON? API free 100/day

HCMAW vs MSFT comparison FAQ

What is MSFT's market cap?

Microsoft Corporation (MSFT) currently screens at market cap $3.71T.

What is MSFT's latest revenue?

Latest reported MSFT revenue for 2026-06-30 was $331.84B.

What is MSFT's net income?

Net income was $133.75B for Microsoft Corporation (MSFT).

How did MSFT revenue change on this page?

Revenue was up 17.8% from 2025-06-30 to 2026-06-30.

How many HCMAW vs MSFT comparison scalars are listed on this page?

This page lists 4 cached comparison scalars for HCMAW vs MSFT: MSFT market cap, MSFT revenue, MSFT net income, and MSFT revenue change.

Where is the HCMAW vs MSFT comparison listed?

The cached HCMAW vs MSFT comparison is listed at https://lician.com/compare/hcmaw-vs-msft.

Not investment advice.

Related research

Popular Stock Comparisons